Cargando…
Characterisation of a LoVo subline resistant to a benzoyl mustard derivative of distamycin A (FCE 24517).
Human colon adenocarcinoma cells (LoVo) resistant to the new antitumor agent FCE 24517 [benzoyl-mustard derivative of distamycin A] (LoVo/24517) are resistant to the selecting agent and related molecules as well as to vinblastine, with marginal or no resistance to other antitumour drugs. Treatment w...
Autores principales: | Capolongo, L., Melegaro, G., Broggini, M., Mongelli, N., Grandi, M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1993
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968750/ https://www.ncbi.nlm.nih.gov/pubmed/8105866 |
Ejemplares similares
-
Biological profile of FCE 24517, a novel benzoyl mustard analogue of distamycin A.
por: Pezzoni, G., et al.
Publicado: (1991) -
Decreased tyrosine phosphorylation in tumour cells resistant to FCE 24517 (tallimustine).
por: Ciomei, M., et al.
Publicado: (1995) -
Laminarin-induced apoptosis in human colon cancer LoVo cells
por: JI, CHEN-FENG, et al.
Publicado: (2014) -
Magnesium homeostasis in colon carcinoma LoVo cells sensitive or resistant to doxorubicin
por: Castiglioni, Sara, et al.
Publicado: (2015) -
Effects of ADMA on gene expression and metabolism in serum-starved LoVo cells
por: Zheng, Ningning, et al.
Publicado: (2016)